Moustakas A - Search Results

1

Commercially Available Preparations of Recombinant Wnt3a Contain Non-Wnt Related Activities Which May Activate TGF-β Signaling.

Carthy JM, Engström U, Heldin CH, Moustakas A. Carthy JM, et al. Among authors: moustakas a. J Cell Biochem. 2016 Apr;117(4):938-45. doi: 10.1002/jcb.25378. Epub 2015 Sep 22. J Cell Biochem. 2016. PMID: 26369756

2

TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. Piek E, et al. Among authors: moustakas a. J Cell Sci. 1999 Dec;112 ( Pt 24):4557-68. doi: 10.1242/jcs.112.24.4557. J Cell Sci. 1999. PMID: 10574705

3

Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.

Morén A, Itoh S, Moustakas A, Dijke P, Heldin CH. Morén A, et al. Among authors: moustakas a. Oncogene. 2000 Sep 7;19(38):4396-404. doi: 10.1038/sj.onc.1203798. Oncogene. 2000. PMID: 10980615

4

Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner.

Kurisaki A, Kose S, Yoneda Y, Heldin CH, Moustakas A. Kurisaki A, et al. Among authors: moustakas a. Mol Biol Cell. 2001 Apr;12(4):1079-91. doi: 10.1091/mbc.12.4.1079. Mol Biol Cell. 2001. PMID: 11294908 Free PMC article.

5

Smad regulation in TGF-beta signal transduction.

Moustakas A, Souchelnytskyi S, Heldin CH. Moustakas A, et al. J Cell Sci. 2001 Dec;114(Pt 24):4359-69. doi: 10.1242/jcs.114.24.4359. J Cell Sci. 2001. PMID: 11792802 Review.

6

From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction.

Moustakas A, Heldin CH. Moustakas A, et al. Genes Dev. 2002 Aug 1;16(15):1867-71. doi: 10.1101/gad.1016802. Genes Dev. 2002. PMID: 12154118 Free article. No abstract available.

7

TGF-beta signaling from a three-dimensional perspective: insight into selection of partners.

Souchelnytskyi S, Moustakas A, Heldin CH. Souchelnytskyi S, et al. Among authors: moustakas a. Trends Cell Biol. 2002 Jul;12(7):304-7. doi: 10.1016/s0962-8924(02)02300-0. Trends Cell Biol. 2002. PMID: 12185845

8

Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.

Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P. Itoh S, et al. Among authors: moustakas a. J Biol Chem. 2003 Feb 7;278(6):3751-61. doi: 10.1074/jbc.M208258200. Epub 2002 Nov 22. J Biol Chem. 2003. PMID: 12446693 Free article.

9

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

Morén A, Hellman U, Inada Y, Imamura T, Heldin CH, Moustakas A. Morén A, et al. Among authors: moustakas a. J Biol Chem. 2003 Aug 29;278(35):33571-82. doi: 10.1074/jbc.M300159200. Epub 2003 Jun 5. J Biol Chem. 2003. PMID: 12794086 Free article.

10

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A. Kurisaki K, et al. Among authors: moustakas a. Mol Cell Biol. 2003 Jul;23(13):4494-510. doi: 10.1128/MCB.23.13.4494-4510.2003. Mol Cell Biol. 2003. PMID: 12808092 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters